Wedmont Private Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
2,190
+81
| +4% | +$10.8K | 0.01% | 582 |
|
|
2025
Q1 | $243K | Sell |
2,109
-1,561
| -43% | -$180K | 0.01% | 579 |
|
|
2024
Q4 | $546K | Buy |
3,670
+2,392
| +187% | +$356K | 0.03% | 352 |
|
|
2024
Q3 | $234K | Sell |
1,278
-1,373
| -52% | -$252K | 0.01% | 586 |
|
|
2024
Q2 | $610K | Buy |
2,651
+238
| +10% | +$54.8K | 0.04% | 298 |
|
|
2024
Q1 | $498K | Buy |
2,413
+446
| +23% | +$92.1K | 0.04% | 320 |
|
|
2023
Q4 | $507K | Buy |
1,967
+743
| +61% | +$192K | 0.04% | 301 |
|
|
2023
Q3 | $323K | Buy |
1,224
+47
| +4% | +$12.4K | 0.03% | 355 |
|
|
2023
Q2 | $328K | Buy |
1,177
+142
| +14% | +$39.6K | 0.04% | 359 |
|
|
2023
Q1 | $293K | Sell |
1,035
-128
| -11% | -$36.2K | 0.04% | 355 |
|
|
2022
Q4 | $325K | Buy |
1,163
+253
| +28% | +$70.7K | 0.05% | 317 |
|
|
2022
Q3 | $243K | Buy |
+910
| New | +$243K | 0.05% | 312 |
|